The epidemiology and evolution of IgA nephropathy over two decades: A single centre experience.
Joshua StorrarRajkumar ChinnaduraiSmeeta SinhaPhilip A KalraPublished in: PloS one (2022)
A variety of clinical and histological factors are important in determining risk of progression in IgAN. Therapeutic interventions, particularly use of immunosuppression, should be individualised and guided by these factors.
Keyphrases